Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.
More >> FDA: Arthritis drugs pose cancer risk to children
More >> FDA: Arthritis drugs pose cancer risk to children
No comments:
Post a Comment